Also known as Loss Of Vision, Vision Loss, and Loss Of Sight
Blindness is the condition of lacking visual perception due to physiological or neurological factors. Various scales have been developed to describe the extent of vision loss and define blindness. Total blindness is the complete lack of form and visual light perception and is clinically recorded as NLP, an abbreviation for "no light perception."Blindness is frequently used to describe severe visual impairment with residual vision. Those described as having only light perception have no more sight than the ability to tell light from dark and the general direction of a light source.
Source: WikipediaThe most common causes of blindness are cataract, chronic glaucoma, and macular degeneration. Other possible causes, such as optic neuritis, are more rare.
Within all the people who go to their doctor with blindness, 49% report having headache, 40% report having diminished vision, and 32% report having dizziness.
Patients with blindness often receive radiographic imaging procedure, x-ray computed tomography, electrocardiogram, glucose measurement, electrolytes panel, cat scan of head, magnetic resonance imaging and cardiac enzymes measurement .
The most commonly prescribed drugs for patients with blindness include brimonidine ophthalmic, atropine (uaa), prednisolone ophthalmic, bimatoprost ophthalmic, travoprost (travatan), tropicamide ophthalmic, phenylephrine (duramax), brinzolamide ophthalmic, timolol, fluorescein ophthalmic, aspirin / dipyridamole, gatifloxacin (zymar) and proparacaine ophthalmic .
Brimonidine Ophthalmic | ||
Atropine (Uaa) | $19 (28 days) | |
Prednisolone Ophthalmic | ||
Bimatoprost Ophthalmic | ||
Travoprost (Travatan) | $95 (28 days) | |
Tropicamide Ophthalmic | ||
Phenylephrine (Duramax) | $9 (28 days) | |
Brinzolamide Ophthalmic | ||
Timolol | $23 (28 days) | |
Fluorescein Ophthalmic | ||
Gatifloxacin (Zymar) | $82 (21 days) | |
Proparacaine Ophthalmic |
Groups of people at highest risk for blindness include age 75+ years age 60-74 years.
< 1 years | 0.1x | |
1-4 years | 0.1x | |
5-14 years | 0.5x | |
15-29 years | 0.6x | |
30-44 years | 0.8x | |
45-59 years | 1.3x | |
60-74 years | 1.8x | |
75+ years | 1.8x |
Male | 1.2x | |
Female | 0.9x |
Black | 0.8x | |
Hispanic | 1.0x | |
White | 1.1x | |
Other | 0.9x |